~October 4th, 2013~
Drug
Development in Rare Diseases: The Regulatory Path to Approval
Dear Families & Friends,
On Day 4 of our October NPD Awareness Month event, we are
highlighting the Food and Drug Administration's presentation during the 2013
NNPDF Family Support and Medical Conference, held in Baltimore, Maryland in
early August.
Andrew Mulberg, M.D., representing
the FDA, discusses the process to get approval for a rare disease clinical
trial. This is especially of interest to the families of the NNPDF as we
currently have TWO clinical trials taking place for Niemann-Pick Disease.
- Acid Sphingomyelinase Deficiancy (ASMD) ~ Enzyme Replacement Therapy
Sponsor: Genzyme, a
Sanofi company, Mount Sinai School of Medicine
To learn more about this trial ~
follow this link.
2. NIH/TRND
Hydroxypropyl-β-cyclodextrin (HP-β-CD) for NPC
Sponsor: National
Institutes of Health
To learn more about this trial ~ follow this
link.
Dr. Andrew Mulberg's August 2013
presentation and professional information is noted
below:
~ October NPD Awareness Month ----
Fundraiser Highlight~
Dillon Papier Golf Tournament
|
Dillon Papier (NPC) and Family |
This year's annual Dillon Papier Charity Golf Tournament is
scheduled for Friday, October 4th, 2012. Registration will begin at 9:00 a.m.,
with a shotgun start at 10:30.
This is a 4-person scramble format
tournament, with prizes for closest to the pin, longest drive, etc., plus
raffles, gift bags, and other prize opportunities.
~NNPDF October Awareness Month~
Every day in the month of October we will be sharing
fundraising ideas and highlight special events to keep the momentum going. So
keep an eye on this web site and the Facebook Awareness Event page for the
latest updates.
Remember that any events you are hosting for October can be
sent to the NNPDF Central Office to be shared with the NPD Community. Contact:
bgreen@nnpdf.org.
See you tomorrow!
No comments:
Post a Comment